Evidence map›Paper›PMID 39155850›Full record

ArticleJournal of cell science2024

Loss of HD-PTP function results in lipodystrophy, defective cellular signaling and altered lipid homeostasis.

Destiny F Schultz, Brian A Davies, Johanna A Payne, Cole P Martin, Annabel Y Minard, Bennett G Childs, Cheng Zhang, Karthik B Jeganathan, Ines Sturmlechner, Thomas A White and 12 more

Abstract read
In one paragraph

Article in Journal of cell science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Destiny F SchultzDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0002-4564-2723
Brian A DaviesDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Johanna A PayneDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Cole P MartinDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0001-6199-1942
Annabel Y MinardDepartment of Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242, USA.ORCID 0000-0003-0715-622X
Bennett G ChildsDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0001-6078-0588
Cheng ZhangDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA.
Karthik B JeganathanDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0001-5587-1266
Ines SturmlechnerDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0003-1272-5618
Thomas A WhiteRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota 55905, USA.
Alain de BruinDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen 9713 AV, The Netherlands.ORCID 0000-0001-8579-2649
Liesbeth HarkemaDepartment of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht 3584 CL, The Netherlands.ORCID 0000-0002-7445-6508
Huiqin ChenDepartment of Biostatistics, Division of Quantitative Sciences, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Michael A DaviesDepartment of Melanoma Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Sarah JachimDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0002-2882-9799
Nathan K LeBrasseurRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0002-2002-0418
Robert C PiperDepartment of Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242, USA.ORCID 0000-0001-9995-5699
Hu LiDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA.
Darren J BakerDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0001-9006-1939
Jan van DeursenDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0002-3042-5267
Daniel D BilladeauDepartment of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0002-2296-9547
David J KatzmannDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA.ORCID 0000-0001-8622-343X

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
The University of Texas MD Anderson Cancer Center SPORE in MelanomaP50CA221703 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DAVIES, MICHAEL · 2019 to 2023
$10.3M
Ubiquitin-Dependent Sorting in Endosomes and the TGNR01GM058202 · NIGMS · UNIVERSITY OF IOWA · PI PIPER, ROBERT C · 1998 to 2025
$8.9M
TRAINING IN TRANSLATIONAL RESEARCH: BENCH TO BEDSIDER25GM055252 · NIGMS · MAYO CLINIC ROCHESTER · PI LUJAN, LUIS, MAHER, LOUIS JAMES · 1996 to 2022
$8.3M
Regulation of Vps4 during ESCRT functionR01GM116826 · NIGMS · MAYO CLINIC ROCHESTER · PI KATZMANN, DAVID J · 2016 to 2019
$1.4M
NIDDK Multidisciplinary Predoctoral Training in Discovery and Translational ResearchT32DK124190 · NIDDK · MAYO CLINIC ROCHESTER · PI DANIEL D BILLADEAU, MARK A. MC NIVEN · 2020 to 2026
$1.3M
Functional Proteomics by Reverse Phase Protein Array in CancerR50CA221675 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LU, YILING · 2017 to 2021
$726k
AIM at MelanomaAmerican Cancer SocietyCancer Fighters of HoustonDr Miriam and Sheldon G. Adelson Medical Research FoundationMelanoma Moon Shots Program of MD AndersonMelanoma Research AllianceNCI NIH HHS P30 CA016672NCI NIH HHS P50 CA221703NCI NIH HHS R50 CA221675NIDDK NIH HHS T32 DK124190NIGMS NIH HHS R01 GM058202NIGMS NIH HHS R01 GM116826NIGMS NIH HHS R25 GM055252NIH HHS R01GM116826
6 · The paper itself

Abstract

His domain protein tyrosine phosphatase (HD-PTP; also known as PTPN23) facilitates function of the endosomal sorting complexes required for transport (ESCRTs) during multivesicular body (MVB) formation. To uncover its role in physiological homeostasis, embryonic lethality caused by a complete lack of HD-PTP was bypassed through generation of hypomorphic mice expressing reduced protein, resulting in animals that are viable into adulthood. These mice exhibited marked lipodystrophy and decreased receptor-mediated signaling within white adipose tissue (WAT), involving multiple prominent pathways including RAS/MAPK, phosphoinositide 3-kinase (PI3K)/AKT and receptor tyrosine kinases (RTKs), such as EGFR. EGFR signaling was dissected in vitro to assess the nature of defective signaling, revealing decreased trans-autophosphorylation and downstream effector activation, despite normal EGF binding. This corresponds to decreased plasma membrane cholesterol and increased lysosomal cholesterol, likely resulting from defective endosomal maturation necessary for cholesterol trafficking and homeostasis. The ESCRT components Vps4 and Hrs have previously been implicated in cholesterol homeostasis; thus, these findings expand knowledge on which ESCRT subunits are involved in cholesterol homeostasis and highlight a non-canonical role for HD-PTP in signal regulation and adipose tissue homeostasis.

Indexed as

Endosomal Sorting Complexes Required for TransportHomeostasisLipodystrophyProtein Tyrosine Phosphatases, Non-ReceptorSignal TransductionAdipose Tissue, WhiteAnimalsCholesterolErbB ReceptorsHumansLipid MetabolismMiceCholesterolEndosomal Sorting Complexes Required for TransportErbB ReceptorsProtein Tyrosine Phosphatases, Non-ReceptorESCRTHD-PTPLipid homeostasisPTPN23Receptor signaling

Identifiers

PMID39155850
PMCPMC11449442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.